logo

Mylan N.V. (MYL)



Trade MYL now with
  Date
  Headline
11/13/2017 9:29:40 AM Theravance And Mylan Submit NDA To FDA For Revefenacin (TD-4208) In Adults With Chronic Obstructive Pulmonary Disease
11/9/2017 7:32:04 AM Mylan Announces U.S. Launch Of Clofarabine Injection, 20 Mg/20 ML (1 Mg/mL) Single-Dose Vials
11/6/2017 7:05:52 AM Mylan N.V. (MYL) Has Raised Its 2017 EPS Estimate To 4.45 - 4.70 From 4.30 - 4.70
11/6/2017 7:02:17 AM Mylan Q3 GAAP EPS $0.16, Up 170% Over Prior Year
11/1/2017 8:37:21 AM Theravance Biopharma And Mylan Report Additional Positive Phase 3 Data For Revefenacin (TD-4208)
11/1/2017 8:02:37 AM Momenta And Mylan Report M834 Did Not Meet Its Primary Pharmacokinetic Endpoints In Phase 1 Study
10/26/2017 5:39:14 AM Mylan N.V. Says Wins UK Court Ruling Related To Copaxone 40 Mg/mL Patent
10/24/2017 4:09:38 PM Sanofi Files Patent Infringement Suit Against Mylan On Lantus And Lantus SoloStar
10/16/2017 6:46:22 PM Mylan Invalidates Allergan's Patents On Restasis
10/5/2017 7:31:22 AM Mylan Announces U.S. Launch Of Moxifloxacin Hydrochloride In 0.8% Sodium Chloride Injection